Matthew Koci Selected Research

phenylalanyl- cyclo(cysteinyl- tyrosyltryptophyl- lysyl- threonyl- penicillamine)threoninamide

1/2020

C-Terminal Amination of a Cationic Anti-Inflammatory Peptide Improves Bioavailability and Inhibitory Activity Against LPS-Induced Inflammation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Matthew Koci Research Topics

Disease

2	Inflammation (Inflammations) 01/2020 - 01/2020
2	Infections 01/2020 - 12/2019
1	Typhoid Fever (Typhoid) 11/2020
1	Weight Loss (Weight Reduction) 01/2020
1	Sepsis (Septicemia) 01/2020
1	Neoplasms (Cancer) 12/2019
1	Occupational Stress 12/2019
1	Salmonella Infections (Salmonellosis) 01/2018

Drug/Important Bio-Agent (IBA)

3	Peptides (Polypeptides)IBA 01/2020 - 12/2019
1	VaccinesIBA 11/2020
1	phenylalanyl- cyclo(cysteinyl- tyrosyltryptophyl- lysyl- threonyl- penicillamine)threoninamideIBA 01/2020
1	Cytidine Triphosphate (CTP)IBA 01/2020
1	Interferon-gamma (Interferon, gamma)IBA 01/2020
1	LipopolysaccharidesIBA 01/2020
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2020
1	Interleukin-6 (Interleukin 6)IBA 01/2020
1	CytokinesIBA 01/2020
1	Immunosuppressive Agents (Immunosuppressants)IBA 12/2019
1	OligosaccharidesIBA 01/2018